99 filings
8-K
GNPX
Genprex Inc
20 Mar 24
Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:25am
8-K
GNPX
Genprex Inc
6 Mar 24
Other Events
9:18am
8-K
GNPX
Genprex Inc
26 Feb 24
Other Events
8:45am
8-K
GNPX
Genprex Inc
5 Feb 24
Departure of Directors or Certain Officers
8:15am
8-K
GNPX
Genprex Inc
2 Feb 24
Departure of Directors or Certain Officers
7:30am
8-K
r3qum
31 Jan 24
Material Modifications to Rights of Security Holders
9:00am
8-K
e4g 32uxtgfuml
5 Jan 24
Regulation FD Disclosure
4:17pm
8-K
l1ydndlejpcnstn2aa
18 Dec 23
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
cq22z531zb jzwcna
13 Dec 23
Entry into a Material Definitive Agreement
4:44pm
8-K
x5p9i 4a32
23 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:44pm
8-K
mhytdg9k0h 28
25 Sep 23
Changes in Registrant's Certifying Accountant
4:20pm
8-K
2feii
8 Sep 23
Regulation FD Disclosure
4:20pm
8-K
mfk7td9a 14c
1 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:17pm
8-K/A
jxzfpg7
21 Aug 23
Changes in Registrant's Certifying Accountant
5:13pm
8-K
6dztdp4hyi0klum
19 Jul 23
Genprex Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:06pm
8-K
2fnbimju86hl
18 Jul 23
Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh
9:06am
8-K
azg19dpx264
14 Jul 23
Changes in Registrant's Certifying Accountant
4:32pm
8-K
eq98fo3fr0w emg
27 Jun 23
Submission of Matters to a Vote of Security Holders
4:28pm
8-K
eshkec vs2
26 May 23
Other Events
4:42pm
8-K/A
q302z 7sk
12 May 23
Changes in Registrant's Certifying Accountant
4:05pm